MAXCYTE, INC. Income Charts

2 years of history · ending 2025-12-31 · SEC EDGAR

Source:10-K · 10-Q

Revenue, Gross Profit, Operating Income & Net Income

Margin (%)

Operating Expenses

Income Breakdown

Revenue
$33M
Cost of Revenue
$6M
Gross Profit
$27M
R&D
$21M
D&A
$4M
Operating Income
$-52M
EBITDA
$-48M
Interest Expense
Interest Income
$7M
Other Income/Expense
$0
Pretax Income
$-45M
Tax Provision
Net Income
$-45M
Gross Margin
81.2%
Operating Margin
-157.1%
Net Margin
-135.1%
Deferred Tax Liabilities
$1M
DTA Valuation Allowance
$67M
Tax Credit Carryforwards
$13M
NOL Carryforwards
$40M
ETR Federal Statutory
21.0%
Operating Lease Cost
$2M
Revenue YoY Variation
-14.5%
Income YoY Variation
-1.4%
No segment data available for this ticker. Source: quarterchart.com.